<p>A study led by researchers at <a href="https://umiamihealth.org/en/sylvester-comprehensive-cancer-center"><strong>Sylvester Comprehensive Cancer Center</strong></a> suggests that CAR-T immunotherapy remains a viable option for patients who have lymphoma that goes into remission before the cell therapy begins. Video available.</p>
Study Shows Cell Therapy Is Safe & Effective For Tumour In Remission menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Cell therapy appears safe and effective for lymphoma in remission medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
CAR-T immunotherapy remains a viable option for patients who have lymphoma a group of blood and lymph tumours that goes into remission before the cell therapy begins, according to a study.Most patients receiving cell therapy, a form of .